$0.11
+0.00 (+3.77%)
Open$0.10
Previous Close$0.11
Day High$0.11
Day Low$0.10
52W High$0.60
52W Low$0.01
Volume—
Avg Volume895.4K
Market Cap47.23M
P/E Ratio—
EPS$-0.38
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+18,345.5% upside
Current
$0.11
$0.11
Target
$20.29
$20.29
$11.90
$20.29 avg
$29.33
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 60.62M | 85.59M | 23.70M |
| Net Income | -188,357,551 | -239,336,151 | -3,056,252 |
| Profit Margin | -310.8% | -295.3% | -12.9% |
| EBITDA | -179,727,538 | -241,057,688 | -4,785,189 |
| Free Cash Flow | — | — | -2,136,953 |
| Rev Growth | -29.2% | -29.2% | +16.7% |
| Debt/Equity | — | — | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.55 | -0.16% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $456.60 | -1.24% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $169.42 | +1.10% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $531.97 | -1.08% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $951.08 | -0.14% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $159.73 | -3.22% | 7.7 | 20.98B |